Peripheral input and its importance for central sensitization

Annals of Neurology

Volumn 74, Issue 5, 2013, Pages 630-636

  Baron, Ralf ^a   Hans, Guy ^b   Dickenson, Anthony H ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; KETAMINE; LIDOCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROKININ; PREGABALIN; SUBSTANCE P;

ALLODYNIA; BACKACHE; BEHAVIOR THERAPY; BRAIN STEM; CENTRAL SENSITIZATION; CHRONIC PAIN; COMORBIDITY; COMPLEX REGIONAL PAIN SYNDROME; CORPUS STRIATUM; DESENSITIZATION; DIFFUSE NOXIOUS INHIBITORY CONTROL; EMISSION TOMOGRAPHY; ENVIRONMENTAL FACTOR; EXCITATORY POSTSYNAPTIC POTENTIAL; FIBROMYALGIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERALGESIA; INFORMATION PROCESSING; LONG TERM POTENTIATION; LOW BACK PAIN; MAGNETOENCEPHALOGRAPHY; MECHANORECEPTOR; MESENCEPHALON; MYOFASCIAL PAIN; NERVE CELL; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PERIPHERAL NERVE; PERIPHERAL NERVE INJURY; PERIPHERAL NERVOUS SYSTEM FUNCTION; PHANTOM PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RECEPTIVE FIELD; REVIEW; SENSITIZATION; SLEEP DISORDER; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; TEMPORAL SUMMATION; TRANSCRANIAL DIRECT CURRENT STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; VULVODYNIA;

EID: 84890761737     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24017     Document Type: Review

References (55)

1. Woolf CJ,. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983; 306: 686-688.
2. D'Mello R, Dickenson AH,. Spinal cord mechanisms of pain. Br J Anaesth 2008; 101: 8-16.
3. Ringkamp M, Raja SN, Campbell JN, Meyer RA,. Peripheral mechanisms of cutaneous nociception. In:, McMahon S, Koltzenburg M, Tracey I, Turk DC, eds. Wall & Melzack's textbook of pain. 6th ed. Philadelphia, PA: Elsevier, 2013: 1-30.
4. Suzuki R, Dickenson A,. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy. Neurosignals 2005; 14: 175-181.
5. Waxman SG,. Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype. Nat Neurosci 2007; 10: 405-409.
6. Bauer CS, Nieto-Rostro M, Rahman W, et al. The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci 2009; 29: 4076-4088.
7. Dickenson AH,. Plasticity: implications for opioid and other pharmacological interventions in specific pain states. Behav Brain Sci 1997; 20: 392-403; discussion 435-513.
8. Herrero JF, Laird JM, Lõpez-García JA,. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 2000; 61: 169-203.
9. Joergensen TS, Henriksen M, Danneskiold-Samsoee B, et al. Experimental knee pain evoke spreading hyperalgesia and facilitated temporal summation of pain. Pain Med 2013; 14: 874-883.
10. Sandkühler J,. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 2009; 89: 707-758.
11. Price DD, Mao J, Frenk H, Mayer DJ,. The N-methyl-d-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994; 59: 165-174.
12. Zhou Q, Price DD, Callam CS, et al. Effects of the n-methyl-d-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome. J Pain 2011; 12: 297-303.
13. O'Neill J, Brock C, Olesen AE, et al. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev 2012; 64: 939-971.
14. Iannetti GD, Zambreanu L, Wise RG, et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci U S A 2005; 102: 18195-18200.
15. Dickenson AH, Sullivan AF,. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci Lett 1987; 83: 207-211.
16. Rygh LJ, Svendsen F, Hole K, Tjølsen A,. Natural noxious stimulation can induce long-term increase of spinal nociceptive responses. Pain 1999; 82: 305-310.
17. Suzuki R, Morcuende S, Webber M, et al. Superficial nk1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci 2002; 5: 1319-1326.
18. Rahman W, Suzuki R, Hunt SP, Dickenson AH,. Selective ablation of dorsal horn nk1 expressing cells reveals a modulation of spinal alpha2-adrenergic inhibition of dorsal horn neurones. Neuropharmacology 2008; 54: 1208-1214.
19. Rygh LJ, Suzuki R, Rahman W, et al. Local and descending circuits regulate long term potentiation and zif268 expression in spinal neurons. Eur J Neurosci 2006; 24: 761-772.
20. Yarnitsky D,. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesth 2010; 23: 611-615.
21. Bannister K, Bee LA, Dickenson AH,. Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics 2009; 6: 703-712.
22. Perrot S, Dickenson AH, Bennett RM,. Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract 2008; 8: 177-189.
23. Pfau DB, Klein T, Putzer D, et al. Analysis of hyperalgesia time courses in humans after painful electrical high-frequency stimulation identifies a possible transition from early to late LTP-like pain plasticity. Pain 2011; 152: 1532-1539.
24. Maier C, Baron R, Tölle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010; 150: 439-450.
25. Freynhagen R, Baron R, Gockel U, Tölle TR,. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006; 22: 1911-1920.
26. Arnould B, Benmedjahed K, Gallais J-L, et al. The impact of herpes zoster and subsequent chronic pain on patients' daily lives. J Public Health 2010; 18: 567-574.
27. Epstein R, Tauc L,. Heterosynaptic facilitation and post-tetanic potentiation in Aplysia nervous system. J Physiol 1970; 209: 1-23.
28. Lindblom U, Verrillo RT,. Sensory functions in chronic neuralgia. J Neurol Neurosurg Psychiatry 1979; 42: 422-435.
29. Campbell JN, Raja SN, Meyer RA, Mackinnon SE,. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 1988; 32: 89-94.
30. Price DD, Long S, Huitt C,. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain 1992; 49: 163-173.
31. Gracely RH, Lynch SA, Bennett GJ,. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992; 51: 175-194.
32. Ochoa JL, Yarnitsky D,. Mechanical hyperalgesias in neuropathic pain patients: dynamic and static subtypes. Ann Neurol 1993; 33: 465-472.
33. Baron R, Baron Y, Disbrow E, Roberts TP,. Brain processing of capsaicin-induced secondary hyperalgesia: a functional MRI study. Neurology 1999; 53: 548-557.
34. Baron R, Baron Y, Disbrow E, Roberts TP,. Activation of the somatosensory cortex during Abeta-fiber mediated hyperalgesia. A MSI study. Brain Res 2000; 871: 75-82.
35. Maihöfner C, Forster C, Birklein F, et al. Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study. Pain 2005; 114: 93-103.
36. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F,. Cortical reorganization during recovery from complex regional pain syndrome. Neurology 2004; 63: 693-701.
37. Pleger B, Tegenthoff M, Ragert P, et al. Sensorimotor retuning [corrected] in complex regional pain syndrome parallels pain reduction. Ann Neurol 2005; 57: 425-429.
38. Yarnitsky D, Granot M, Nahman-Averbuch H, et al. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012; 153: 1193-1198.
39. Petersen KL, Fields HL, Brennum J, et al. Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 2000; 88: 125-133.
40. Geha PY, Baliki MN, Chialvo DR, et al. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain 2007; 128: 88-100.
41. Meeus M, Nijs J,. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 2007; 26: 465-473.
42. Woolf CJ,. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152: S2-S15.
43. Goncalves L, Dickenson AH,. Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur J Neurosci 2012; 36: 3204-3213.
44. Navratilova E, Xie JY, Okun A, et al. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci U S A 2012; 109: 20709-20713.
45. Rocha AP, Kraychete DC, Lemonica L, et al. Pain: current aspects on peripheral and central sensitization. Rev Bras Anestesiol 2007; 57: 94-105.
46. Latremoliere A, Woolf CJ,. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10: 895-926.
47. Nijs J, Paul, van Wilgen C, Van Oosterwijck J, et al. How to explain central sensitization to patients with 'unexplained' chronic musculoskeletal pain: practice guidelines. Man Ther 2011; 16: 413-418.
48. Nijs J, Van Houdenhove B, Oostendorp RA,. Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice. Man Ther 2010; 15: 135-141.
49. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ,. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 1995; 18: 360-368.
50. Correa-Illanes G, Calderõn W, Roa R, et al. Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster. Local Reg Anesth 2010; 3: 77-83.
51. Davies PS, Galer BS,. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64: 937-947.
52. Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010 C116 Study Group. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008; 7: 1106-1112.
53. Grant M,. EMDR: A new treatment for trauma and chronic pain. Complement Ther Nurs Midwifery 2000; 6: 91-94.
54. Grant M, Threlfo C,. EMDR in the treatment of chronic pain. J Clin Psychol 2002; 58: 1505-1520.
55. Flik CE, de Roos C,. Eye movement desensitisation and reprocessing (EMDR) as a treatment for phantom limb pain. Tijdschr Psychiatr 2010; 52: 589-593.